Strategies for transporting nanoparticles across the blood–brain barrier
The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Nanoparticles have been widely deployed for brain-targeted delivery. Drugs can be embedded either in a matrix or deposited on the surface of nanoparticles, and the whole particle can cross the BBB effectively and be targeted to specific parts of the body in a controllable manner.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,805
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
Maeda, H. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100070g · Cited by 998
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Madani, F., Lindberg, S., Langel, Ü., Futaki, S., & Gräslund, A. (2011) · Journal of Biophysics · doi:10.1155/2011/414729 · Cited by 984
Nanoparticulate systems for brain delivery of drugs
Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958
Cell‐penetrating peptides: 20 years later, where do we stand?
Bechara, C., & Sagan, S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.04.031 · Cited by 857
Cell-penetrating peptides: classes, origin, and current landscape
Milletti, F. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.002 · Cited by 813
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 802
Research works printed but not linked: 8
- Weidle, 2015, Cancer Genomics Proteomics, 12, 167
- Schmid-Brunclik, 2008, Am. J. Physiol.: Regul., Integr. Comp. Physiol., 295, R864
- Hagg, 2006, J. Neurotrauma, 23, 264
- Kozler, 2012, Neuroendocrinol. Lett., 33, 782
- Piraux, 2015, J. Appl. Phys., 117
- Zheng, 2015, Int. J. Clin. Exp. Med., 8, 1658
- Nounou, 2014, Cancer Res., 74
- Maletinska, 2000, Cancer Res., 60, 2300
Cited by
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
“70,71 Moreover, for invertebrates that lack a vascularized circulatory system, astrocytes are the main components of the barrier separating humoral fl uids from the CNS. 72 Pericytes .”
BackgroundInfluentialCrossing the blood-brain barrier with nanoparticles
Zhou, Y., Peng, Z., Seven, E. S., & Leblanc, R. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.015 · Cited by 837
“such as non-invasiveness, low cost, good biodegradability and longterm stability, ease of synthesis, high targeting efficiency, and high controllability to load and release drugs across the BBB [40,41].”
BackgroundThe therapeutic potential of nanobodies
Jovčevska, I., & Muyldermans, S. (2020) · BioDrugs · doi:10.1007/s40259-019-00392-z · Cited by 749
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Li, W., Zhang, H., Assaraf, Y. G., Zhao, K., Xu, X., Xie, J., Yang, D.-H., & Chen, Z.-S. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.05.001 · Cited by 673
“Compared to freely diffusing hydrophobic drugs, drug-loaded NPs have higher solubility, in vivo stability, increased specific bio- distribution and better control of drug release (Kim et al., 2009; Zhang et al., 2011).”
BackgroundSelf-citationProgress and perspectives on targeting nanoparticles for brain drug delivery
Gao, H. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.05.013 · Cited by 495
Overcoming blood–brain barrier transport: Advances in nanoparticle-based drug delivery strategies
Ding, S., Khan, A. I., Cai, X., Song, Y., Lyu, Z., Du, D., Dutta, P., & Lin, Y. (2020) · Materials Today · doi:10.1016/j.mattod.2020.02.001 · Cited by 440
Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges
Zhang, W., Mehta, A., Tong, Z., Esser, L., & Voelcker, N. H. (2021) · Advanced Science · doi:10.1002/advs.202003937 · Cited by 430
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Guan, F., Wang, R., Yi, Z., Luo, P., Liu, W., Xie, Y., Liu, Z., Xia, Z., Zhang, H., & Cheng, Q. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02124-y · Cited by 371
Han, L., & Jiang, C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.023 · Cited by 358
Blood-Brain Delivery Methods Using Nanotechnology
Teleanu, D. M., Chircov, C., Grumezescu, A. M., Volceanov, A., & Teleanu, R. I. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040269 · Cited by 305
“Moreover, they can avoid phagocytosis by the reticuloendothelial system, thus improving the concentration of drugs in the brain [41].”
BackgroundBlood-brain barrier transport machineries and targeted therapy of brain diseases
Barar, J., Rafi, M. A., Pourseif, M. M., & Omidi, Y. (2016) · BioImpacts · doi:10.15171/bi.2016.30 · Cited by 257
Akhtar, A., Andleeb, A., Waris, T. S., Bazzar, M., Moradi, A.-R., Awan, N. R., & Yar, M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.021 · Cited by 240
Dendrimer-Based Drug Delivery Systems for Brain Targeting
Zhu, Y., Liu, C., & Pang, Z. (2019) · Biomolecules · doi:10.3390/biom9120790 · Cited by 220
“In addition, there are still some challenges to overcome for nose-to-brain delivery such as obstruction of the nasal epithelial barrier, rapid clearance from nasal cavity, limited penetration of drugs from nerve entry points [68,92], and nasal absorption irregularities during disease states.”
BackgroundAntioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries
Amani, H., Habibey, R., Hajmiresmail, S. J., Latifi, S., Pazoki-Toroudi, H., & Akhavan, O. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01689a · Cited by 219
Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy
Zhu, Y., Liang, J., Gao, C., Wang, A., Xia, J., Hong, C., Zhong, Z., Zuo, Z., Kim, J., Ren, H., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.036 · Cited by 168
Electrospun nanofibers for cancer diagnosis and therapy
Chen, Z., Chen, Z., Zhang, A., Hu, J., Wang, X., & Yang, Z. (2016) · Biomaterials Science · doi:10.1039/c6bm00070c · Cited by 168
Dye-doped silica nanoparticles: synthesis, surface chemistry and bioapplications
Gubala, V., Giovannini, G., Kunc, F., Monopoli, M. P., & Moore, C. J. (2020) · Cancer Nanotechnology · doi:10.1186/s12645-019-0056-x · Cited by 165
Nanomaterials for Drug Delivery to the Central Nervous System
Teleanu, D. M., Negut, I., Grumezescu, V., Grumezescu, A. M., & Teleanu, R. I. (2019) · Nanomaterials · doi:10.3390/nano9030371 · Cited by 156
“Receptor-mediated transcytosis is a key transportation path for endogenous peptides, like insulin, transferrin, insulin-like growth factor and nicotinic acetylcholine receptor [50].”
BackgroundTargeted Drug Delivery: Trends and Perspectives
Ashique, S., Sandhu, N. K., Chawla, V., & Chawla, P. A. (2021) · Current Drug Delivery · doi:10.2174/1567201818666210609161301 · Cited by 154
Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy
Zottel, A., Paska, A. V., & Jovčevska, I. (2019) · Materials · doi:10.3390/ma12101588 · Cited by 158
“There are different methods for increasing transport across the BBB like disruption with osmotic shock, ultrasound and magnetic gradient [91].”
BackgroundMethodInfluentialThe therapeutic potential of targeting ABC transporters to combat multi-drug resistance
Bugde, P., Biswas, R., Merien, F., Lu, J., Liu, D.-X., Chen, M., Zhou, S., & Li, Y. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1310841 · Cited by 135
Multiple sclerosis: molecular pathogenesis and therapeutic intervention
Boutitah-Benyaich, I., Eixarch, H., Villacieros‐Álvarez, J., Hervera, A., Cobo‐Calvo, Á., Montalbán, X., & Espejo, C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02415-4 · Cited by 160
“463 Furthermore, nanoparticles may be easily surface modi fi ed with functional biomaterials, allowing them to gain enhanced properties.”
Muniswamy, V. J., Raval, N., Gondaliya, P., Tambe, V., Kalia, K., & Tekade, R. K. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.11.035 · Cited by 136
Reddy, S., Tatiparti, K., Sau, S., & Iyer, A. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.04.008 · Cited by 128
Teixeira, M. I., Lopes, C. M., Amaral, M. H., & Costa, P. C. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.01.005 · Cited by 128
Ferraris, C., Cavalli, R., Panciani, P. P., & Battaglia, L. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s231479 · Cited by 131
Zhou, Y., Liyanage, P. Y., Devadoss, D., Rios Guevara, L. R., Cheng, L., Graham, R. M., Chand, H. S., Al-Youbi, A. O., Bashammakh, A. S., El-Shahawi, M. S., et al. (2019) · Nanoscale · doi:10.1039/c9nr08194a · Cited by 129
Moura, R. P., Martins, C., Pinto, S. F. T., Sousa, F., & Sarmento, B. F. C. C. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1583205 · Cited by 131
Perspectives on Dual Targeting Delivery Systems for Brain Tumors
Gao, H. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9687-4 · Cited by 129
Chen, Y., He, Y., Han, J., Wei, W., & Chen, F. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1258640 · Cited by 116
Su, Y., Sun, B., Gao, X., Dong, X., Fu, L., Zhang, Y., Li, Z., Wang, Y., Jiang, H., & Han, B. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01165 · Cited by 119
Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases
Anthony, D. P., Hegde, M., Shetty, S. S., Rafic, T., Mutalik, S., & Rao, B. S. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119326 · Cited by 110
Huang, N., Cheng, S., Zhang, X., Tian, Q., Pi, J., Tang, J., Huang, Q., Wang, F., Chen, J., Xie, Z., et al. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.08.029 · Cited by 109
Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives
Kouhi, A., Pachipulusu, V., Kapenstein, T., Hu, P., Epstein, A. L., & Khawli, L. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126442 · Cited by 114
Lu, L., Qi, S., Chen, Y., Luo, H., Huang, S., Yu, X. M., Luo, Q., & Zhang, Z. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119987 · Cited by 110
Polymeric Nanoparticles for the Treatment of Malignant Gliomas
Mahmoud, B. S., Alamri, A. H., & McConville, C. (2020) · Cancers · doi:10.3390/cancers12010175 · Cited by 110
“The intranasal route is beneficial in terms of being convenient to patients, allowing for rapid absorption and avoiding first pass metabolism [92].”
BackgroundRibeiro, T. D. C., Sábio, R. M., Luiz, M. T., Canto‐de‐Souza, L., Fonseca‐Santos, B., da Silva, L. C. C., Fantini, M. C. D. A., Planeta, C. S., & Chorilli, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091976 · Cited by 111
Abdelrahman, F. E., Elsayed, I., Gad, M. K., Elshafeey, A. H., & Mohamed, M. I. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.050 · Cited by 98
“This would help the spanlastics fraction, absorbed from the nasal to the systemic circulation, to pass through the BBB and escape from opsonisation and phagocytosis (Owens and Peppas, 2006; Wu et al., 2008; Zhang et al., 2016).”
Zhao, L., Li, Y., Zhu, J., Sun, N., Song, N., Xing, Y. T., Huang, H., & Zhao, J. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0462-6 · Cited by 96
Kang, S., Duan, W., Zhang, S., Chen, D., Feng, J., & Qi, N. (2020) · Theranostics · doi:10.7150/thno.41322 · Cited by 91
“not taken up by the brain capillary endothelial cells so most of the potential therapeutic drugs cannot enter the brain for the treatment of glioma [3].”
BackgroundGold Nanoparticles in Glioma Theranostics
Norouzi, M. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104753 · Cited by 94
The Nasal–Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases
Qiu, Y., Huang, S., Peng, L., Yang, L., Zhang, G., Liu, T., Yan, F., & Peng, X. (2025) · MedComm · doi:10.1002/mco2.70213 · Cited by 114
Xu, R., Wang, J., Xu, J., Song, X., Huang, H., Feng, Y., & Fu, C. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s236922 · Cited by 92
Mendiratta, S., hussein, M., Nasser, H. A., & Ali, A. (2019) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201900195 · Cited by 93
Overcoming the blood-brain barrier: Exosomes as theranostic nanocarriers for precision neuroimaging
Li, C., Qin, S., Wen, Y., Zhao, W. G., Huang, Y., & Liu, J. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.08.002 · Cited by 91
Recent advances in the development of nanomedicines for the treatment of ischemic stroke
Tian, X., Fan, T., Zhao, W., Abbas, G., Han, B. R., Zhang, K., Li, N., Liu, N., Liang, W., Huang, H., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.01.023 · Cited by 90
Alotaibi, B. S., Buabeid, M. A., Ibrahim, N. A., Kharaba, Z. J., Ijaz, M., Noreen, S., & Murtaza, G. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s333657 · Cited by 87
“The recent tests focused on using poly(lactide-coglycolic) acid as a material to synthesize nanoparticles for encapsulating therapeutic agents for Alzheimer’s disease and brain cancer.(100) It has been demonstrated that polymer nanoparticles are more effective at penetrating the brain, reducing oxidative stress, infla…”
BackgroundYamamoto, Y., Välitalo, P. A. J., Huntjens, D. R. H., Proost, J. H., Vermeulen, A., Krauwinkel, W. J. J., Beukers, M. W., van den Berg, D., Hartman, R., Wong, Y. C., et al. (2017) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12250 · Cited by 85
Roy, B., Lee, E. J., Li, T., & Rampersaud, M. (2022) · Genes · doi:10.3390/genes13030425 · Cited by 89
Wang, Y., Li, S., Shen, S., & Wang, J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.039 · Cited by 80
Neuro-nanotechnology: diagnostic and therapeutic nano-based strategies in applied neuroscience
Shabani, L., Abbasi, M., Azarnew, Z., Amani, A. M., & Vaez, A. (2023) · BioMedical Engineering OnLine · doi:10.1186/s12938-022-01062-y · Cited by 86
“Polymeric nanoparticles are flexible enough to be capable of delivering a broad variety of medications, for instance, through interactions that are hydrophobic, hydrophilic, or electrostatic, as well as reactive covalent bonds [179].”
BackgroundMeng, J., Agrahari, V., & Youm, I. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9698-1 · Cited by 84
Micro- and nanotechnology for neural electrode-tissue interfaces
Liu, S., Zhao, Y., Hao, W., Zhang, X., & Ming, D. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112645 · Cited by 81
New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease
Ouyang, Q., Meng, Y., Zhou, W., Tong, J., Cheng, Z., & Zhu, Q. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1927055 · Cited by 84
“According to studies, approximately 98% of the small molecule drugs and almost 100% of the large molecule drugs, such as peptides and gene drugs, have difficulty entering the brain, which poses a great challenge in the treatment of brain diseases [55].”
BackgroundChe, H., Zhou, M., Zhang, T., Zhang, L., Ding, L., Yanagita, T., Xu, J., Xue, C., & Wang, Y. (2017) · Food & Function · doi:10.1039/c7fo01342f · Cited by 81
Self-citationEngineered exosomes with enhanced stability and delivery efficiency for glioblastoma therapy
Wang, Y., Huo, Y., Zhao, C., Liu, H., Shao, Y., Zhu, C., An, L., Chen, X., & Chen, Z. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.02.015 · Cited by 84
Emerging transporter-targeted nanoparticulate drug delivery systems
Su, H., Wang, Y., Liu, S., Wang, Y., Liu, Q., Liu, G., & Chen, Q. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.10.005 · Cited by 78
Nanotechnology to improve the Alzheimer’s disease therapy with natural compounds
Ramalho, M. J., Andrade, S., Loureiro, J. A., & do Carmo Pereira, M. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-019-00694-3 · Cited by 75
Promising Nanotechnology Approaches in Treatment of Autoimmune Diseases of Central Nervous System
Chountoulesi, M., & Demetzos, C. (2020) · Brain Sciences · doi:10.3390/brainsci10060338 · Cited by 79
“Once again, nanotechnology may solve these problems, with nanoparticles crossing the BBB and facilitating targeting to specific cells, as highlighted in the below-described literature examples.”
BackgroundInfluentialCai, K., Wang, A. Z., Yin, L., & Cheng, J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.034 · Cited by 80
“presence of blood brain barrier (BBB) prevents the central nerve system from most circulating NM [172] while monocytes and macrophages”
BackgroundRole of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy
Gupta, S. K., Singh, P., Ali, V., & Verma, M. (2020) · Oncology Reviews · doi:10.4081/oncol.2020.448 · Cited by 79
Young, A. T., Cornwell, N., & Daniele, M. A.-A. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201700239 · Cited by 77
Nanomedicine-based immunotherapy for central nervous system disorders
Hanif, S., Muhammad, P., Chesworth, R., Rehman, F. U., Qian, R., Zheng, M., & Shi, B. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0429-z · Cited by 75
Thangudu, S., Cheng, F., & Su, C. (2020) · Polymers · doi:10.3390/polym12123055 · Cited by 66
“Transferrin receptor [43], Nicotinic acetylcholine receptor [44], Insulin receptor [45], Leptin receptor [45], Lipoprotein receptor [46], Neonatal Fc receptor [38], Diphtheria toxin receptor [45] Taurine transporter [37], Amino acid transporter [47], Polypeptide transporter [37], Organic anio transporter [45], ATP-bin…”
BackgroundLin, R., Jin, L., Xue, Y., Zhang, Z., Huang, H., Chen, D., Liu, Q., Mao, Z., Wu, Z., & Tao, Q. (2024) · Advanced Science · doi:10.1002/advs.202306675 · Cited by 85
Non-invasive aerosol delivery and transport of gold nanoparticles to the brain
Raliya, R., Saha, D., Chadha, T. S., Raman, B., & Biswas, P. (2017) · Scientific Reports · doi:10.1038/srep44718 · Cited by 67
Antibody-conjugated mesoporous silica nanoparticles for brain microvessel endothelial cell targeting
Bouchoucha, M., Béliveau, É., Kleitz, F., Calon, F., & Fortin, M. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01385j · Cited by 71
Wang, C., Wang, D., Xu, J., Yanagita, T., Xue, C., Zhang, T., & Wang, Y. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.04.017 · Cited by 65
Self-citationNanomaterials for Protein Delivery in Anticancer Applications
Yau, A., Lee, J., & Chen, Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020155 · Cited by 64
PDA-Based Drug Delivery Nanosystems: A Potential Approach for Glioma Treatment
Wu, H., Wei, M., Xu, Y., Li, Y., Zhai, X., Su, P., Ma, Q., & Zhang, H. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s378217 · Cited by 67
“RMT (eg, low-density lipoprotein (LDL) receptor, transferrin (Tf) receptor, lactoferrin (Lf) receptor, insulin receptor, and receptors for insulin-like growth factors (IGF-1 and IGF-2)).(112) CMT and RMT ligands have been continually utilized for drug delivery as molecular “Trojan horses” for nanocarriers.”
MethodCell-permeable NF-κB inhibitor-conjugated liposomes for treatment of glioma
Zhang, Y., Zhang, L., Hu, Y., Jiang, K., Li, Z., Lin, Y.-Z., Wei, G., & Lu, W. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.016 · Cited by 62
Неганова, М. Е., Aleksandrova, Y. R., Sukocheva, O. A., & Klochkov, S. G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.06.011 · Cited by 58
Nanoparticle-Delivered 2-PAM for Rat Brain Protection against Paraoxon Central Toxicity
Pashirova, T. N., Zueva, I. V., Petrov, K. A., Babaev, V. M., Lukashenko, S. S., Rizvanov, I. K., Souto, E. B., Nikolsky, E. E., Zakharova, L. Y., Masson, P., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b04163 · Cited by 56
Advances in designing of polymeric micelles for biomedical application in brain related diseases
Kaur, J., Gulati, M., Kapoor, B., Jha, N. K., Gupta, P. K., Gupta, G., Chellappan, D. K., Devkota, H. P., Prasher, P., Ansari, M. S., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109960 · Cited by 56
Wu, H., Zhou, Y., Xu, L., Tong, L., Wang, Y., Liu, B., Yan, H., & Sun, Z. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.706105 · Cited by 65
Antibodies for the Treatment of Brain Metastases, a Dream or a Reality?
Cavaco, M. C., Gaspar, D., Castanho, M. A. R. B., & Neves, V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12010062 · Cited by 56
Liu, Y., Liu, J., Zhang, J., Li, X., Lin, F., Zhou, N., Yang, B., & Lu, L. (2018) · ACS Omega · doi:10.1021/acsomega.8b01169 · Cited by 55
The Role of Nanomaterials in Stroke Treatment: Targeting Oxidative Stress
Song, G., Zhao, M., Chen, H., Lenahan, C., Zhou, X., Ou, Y., & He, Y. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8857486 · Cited by 54
PMPC Modified PAMAM Dendrimer Enhances Brain Tumor‐Targeted Drug Delivery
Ban, J., Li, S., Zhan, Q., Li, X., Xing, H., Chen, N., Long, L., Hou, X., Zhao, J., & Yuan, X. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202000392 · Cited by 51
Raghav, M., Gupta, V., Awasthi, R., Singh, A. K., & Kulkarni, G. T. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104756 · Cited by 63
Li, J., Long, Q., Ding, H., Wang, Y., Luo, D., Li, Z., & Zhang, W. (2024) · Advanced Science · doi:10.1002/advs.202308677 · Cited by 57
Mohapatra, P., Gopikrishnan, M., Doss, C. G. P., & Chandrasekaran, N. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s442520 · Cited by 53
“38 The two most important criteria to consider when choosing an efficient method to create varied-sized NPs are the easy-to-functionalize property and strong biocompatibility of the changed molecule.”
Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery
Nozhat, Z., Heydarzadeh, S., Shahriari‐Khalaji, M., Wang, S., Iqbal, M. Z., & Kong, X. (2023) · Biomaterials Science · doi:10.1039/d2bm01996e · Cited by 48
Recent Advances in Nanomedicine and Survivin Targeting in Brain Cancers
Mazur, J., Roy, K., & Kanwar, J. R. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0286 · Cited by 50
Nosocomial Infections and Role of Nanotechnology
Ananda, T., Modi, A., Chakraborty, I., Managuli, V., Mukhopadhyay, C., & Mazumder, N. (2022) · Bioengineering · doi:10.3390/bioengineering9020051 · Cited by 47
“Industrial production, quality control, and storage stability of nanoparticles must be assessed to ensure their purity and safe administration in a biological system [72].”
BackgroundRecent advances in zwitterionic nanoscale drug delivery systems to overcome biological barriers
Ouyang, X., Liu, Y., Zheng, K., Pang, Z., & Peng, S. (2023) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2023.100883 · Cited by 65
“…lipoprotein (LDL) receptor-related protein, nicotinic acetylcholine receptor, insulin-like growth factor receptor, diphtheria toxin receptor, scavenger receptor call B type, leptin receptor and the neonatal Fc receptor are a few of the many receptors that are over-expressed on the BBB [114–118] .”
BackgroundEnhancement of drug permeability across blood brain barrier using nanoparticles in meningitis
Nair, K. G. S., Velmurugan, R., & Kumar, S. S. (2018) · Inflammopharmacology · doi:10.1007/s10787-018-0468-y · Cited by 48
Kassem, L. M., Ibrahim, N., & Farhana, S. A. (2020) · Journal of Nanotechnology · doi:10.1155/2020/8147080 · Cited by 50
Highlights in targeted nanoparticles as a delivery strategy for glioma treatment
Luiz, M. T., Filippo, L. D. D., Tofani, L. B., de Araújo, J. T. C., Dutra, J. A. P., Marchetti, J. M., & Chorilli, M. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120758 · Cited by 44
Nanosized Camptothecin Conjugates for Single and Combined Drug Delivery
Chen, K., Sun, Y., Wang, M., & Cheng, X. (2016) · European Journal of BioMedical Research · doi:10.18088/ejbmr.2.1.2016.pp8-14 · Cited by 42
“Nanotechnology has achieved huge accomplishments in the past few decades, providing scientists with lots of techniques to fabricate nanoparticles for different objectives (14-22).”
BackgroundShi, H., Zou, J., Zhang, T., Che, H., Gao, X., Wang, C., Wang, Y., & Xue, C. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b04565 · Cited by 41
Self-citationProgress in Remotely Triggered Hybrid Nanostructures for Next-Generation Brain Cancer Theranostics
Thorat, N. D., Townely, H., Brennan, G., Parchur, A. K., Silien, C., Bauer, J., & Tofail, S. A. M. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01173 · Cited by 42
Turovsky, E. A., Baryshev, A. S., & Plotnikov, E. Y. (2024) · Nanomaterials · doi:10.3390/nano14020160 · Cited by 40
“To enhance the active transport of nanoparticles into the brain, their modification with receptor ligands is used: transferrin receptor, insulin receptor, low-density lipoprotein receptor (LDLR), angiopep-2 receptor, and the receptor for advanced glycation end-products (RAGE) [10,11].”
MethodShi, X., Miao, W.-M., Pang, D., Wu, J., Tong, Q., Li, J.-X., Luo, J., Li, W., Du, J., & Wang, J. (2019) · Biomaterials Science · doi:10.1039/c9bm01750j · Cited by 39
Self-citationDextran-coated iron oxide nanoparticle-induced nanotoxicity in neuron cultures
Badman, R. P., Moore, S. L., Killian, J. L., Feng, T., Cleland, T. A., Hu, F., & Wang, M. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-67724-w · Cited by 41
Magnetic drilling enhances intra-nasal transport of particles into rodent brain
Jafari, S., Mair, L. O., Weinberg, I. N., Baker-McKee, J., Hale, O., Watson-Daniels, J., English, B. W., Stepanov, P. Y., Ropp, C., Atoyebi, O. F., et al. (2018) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2018.08.048 · Cited by 40
Spencer, A. P., Torrado, M., Custódio, B., Silva-Reis, S. C., Santos, S. D., Leiro, V., & Pêgo, A. P. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020192 · Cited by 46
Progress of nanoparticle drug delivery system for the treatment of glioma
Lai, G., Wu, H., Yang, K., Hu, K., Yan, Z., Chen, X., Fu, F., Li, J., Xie, G., Wang, H., et al. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1403511 · Cited by 40
Nanorobots mediated drug delivery for brain cancer active targeting and controllable therapeutics
Xu, M., Qin, Z., Chen, Z., Wang, S., Peng, L., Li, X., & Yuan, Z. (2024) · Discover Nano · doi:10.1186/s11671-024-04131-4 · Cited by 46
Metadata
- Authors
- Zhang, T.-T., Li, W., Meng, G., Wang, P., & Liao, W.
- Affiliations
- Department of Food Science and Technology
- IHRC
- Tongde Hospital of Zhejiang Province (CN)
- North Carolina Agricultural and Technical State University (US)
- South China University of Technology (CN)
- Corresponding author
- Liao, Wenzhen
- Venue
- Biomaterials Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2016
- Volume
- 4
- Issue
- 2
- Pages
- 219-229
- ISSN
- 2047-4830 (ISSN-L)
- 2047-4849
- OpenAlex
- W2190350005
- Cited by
- 308
- References
- 115
- Citations by year
- 2026: 6 · 2025: 35 · 2024: 40 · 2023: 31 · 2022: 33 · 2021: 33 · 2020: 41 · 2019: 21 · 2018: 23 · 2017: 24 · 2016: 21
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biomaterials Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- blood-brain barrier, nanoparticles, brain drug delivery, central nervous system disorders, nanomedicine
- MeSH terms
- Biological Transport, Blood-Brain Barrier, Brain, Central Nervous System, Central Nervous System Diseases, Humans, Drug Delivery Systems, Nanotechnology, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.